How were Sienna Biopharmaceuticals' earnings last quarter?

Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) issued its earnings results on Thursday, March, 14th. The company reported ($0.93) EPS for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10.

What other stocks do shareholders of Sienna Biopharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX) , Allena Pharmaceuticals (ALNA) , Spectrum Pharmaceuticals (SPPI) , Selecta Biosciences (SELB) , Viking Therapeutics (VKTX) , Novavax (NVAX) , Synergy Pharmaceuticals (SGYP) , Zealand Pharma A/S (ZEAL) and Bausch Health Companies (BHC) .

When did Sienna Biopharmaceuticals IPO?

Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets served as the underwriters for the IPO.

NASDAQ:SNNA

Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free SNNA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.11
▼
$0.17
50-Day Range: $0.14
▼
$0.14
52-Week Range: $0.06
▼
$3.80

Volume: 13.32 million shs
Average Volume: 1.87 million shs
Market Capitalization: $4.20 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Sienna Biopharmaceuticals alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)

Sienna Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

Click for my No. 1 investment, all free of charge, click here.

SNNA Stock News Headlines

April 16, 2024 | msn.com

Sienna Miller’s wedding and baby number three joy

April 12, 2024 | msn.com

Sienna Wildgust, NHRA Pro Stock's Youngest Female Racer Is 'Breath of Fresh Air'

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

April 9, 2024 | msn.com

Hollyoaks airs gunshot twist in Sienna Blake story

April 9, 2024 | msn.com

Sienna Mapelli Mozzi ‘looks exactly’ like mom Princess Beatrice

April 9, 2024 | msn.com

Revealed: Who Princess Beatrice's rarely seen daughter Sienna looks like

April 8, 2024 | msn.com

Princess Beatrice 'a fantastic mum' to daughter Sienna, stepmum to Wolfie

April 6, 2024 | msn.com

Hollyoaks star Anna Passey fears potential end of Sienna and Ste's friendship

April 19, 2024 | Altimetry (Ad)

Secret Bull Market Starts in This Unusual Sector

April 2, 2024 | uk.news.yahoo.com

Hollyoaks confirms hostage drama for Sienna as Warren plan backfires

April 2, 2024 | msn.com

Hollyoaks spoiler: Sienna records Warren's confession

April 2, 2024 | msn.com

Morgan Coleman, Sienna Chirieleison, Alexis Kuntz lead Trinity lacrosse past Northern

April 1, 2024 | msn.com

Hollyoaks confirms terrifying home invasion as Sienna Blake is held at gunpoint

March 27, 2024 | msn.com

Former Sienna guard Elisa Mevius commits to Oregon women’s basketball

March 26, 2024 | uk.style.yahoo.com

Sienna Miller's Missoma earrings are on every A-lister this season

March 25, 2024 | msn.com

Sienna Miller's affordable earrings are top of our wish list

March 15, 2024 | msn.com

Grandview girls basketball star Sienna Betts named Colorado Gatorade Player of the Year

March 12, 2024 | msn.com

Sienna Miller Just Wore A Perfect Rainy Day Outfit, Including One Of Her Favourite High Street Brands

March 12, 2024 | msn.com

Sienna Miller's Missoma earrings are a must-have for the new season

March 10, 2024 | msn.com

Ciara Celebrates Women’s Day With Sienna in Disneyland as Russell Wilson Fights for NFL Future

March 8, 2024 | msn.com

Sienna Miller, 42, and rarely-seen boyfriend Oli Green, 27, make stunning appearance after welcoming baby girl

March 7, 2024 | msn.com

Hollyoaks confirms major death twist for Sienna Blake as dastardly James Nightingale goes too far

March 5, 2024 | sg.news.yahoo.com

EXCLUSIVE: Issa Rae on Her Mission for Healthy Hair Journeys in New Sienna Naturals Campaign

March 5, 2024 | msn.com

Sienna Miller just wore the 'cool girl' coat trend of the season

March 4, 2024 | msn.com

Nail Sienna Miller's $2,798 Leather Trench Style for Under $50

March 3, 2024 | msn.com

Sienna Miller Embraces Love Amidst 14-Year Age Gap with Oli Green

March 3, 2024 | yahoo.com

Fans Are Loving Ciara’s Daughter Sienna’s ‘Daddy Daughter Dance’ With Russell Wilson in Sweet Video

See More Headlines

Receive SNNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sienna Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/14/2019
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:SNNA
CUSIP: N/A
CIK: 1656328
Web: www.siennabio.com
Phone: (818) 629-2256
Fax: N/A
Employees: 39
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($3.59)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-73,470,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -177.36%
Return on Assets: -52.22%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 15.27
Quick Ratio: 15.27

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.27 per share
Price / Book: 0.11

Miscellaneous

Outstanding Shares: 30,908,000
Free Float: N/A
Market Cap: $4.20 million
Optionable: Not Optionable
Beta: 2.67

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Frederick C. Beddingfield
President, Chief Executive Officer & Director
Majed Kheir
Vice President-Operations
Paul F. Lizzul
Chief Medical Officer
Silvio Traversa
Chief Scientific Officer
Todd J. Harris
Director & Head-Corporate Development

Key Competitors

View All Competitors

SNNA Stock Analysis - Frequently Asked Questions

How were Sienna Biopharmaceuticals' earnings last quarter?: Sienna Biopharmaceuticals, Inc. (NASDAQ:SNNA) issued its earnings results on Thursday, March, 14th. The company reported ($0.93) EPS for the quarter, missing analysts' consensus estimates of ($0.83) by $0.10.
What other stocks do shareholders of Sienna Biopharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Sienna Biopharmaceuticals investors own include SCYNEXIS (SCYX), Allena Pharmaceuticals (ALNA), Spectrum Pharmaceuticals (SPPI), Selecta Biosciences (SELB), Viking Therapeutics (VKTX), Novavax (NVAX), Synergy Pharmaceuticals (SGYP), Zealand Pharma A/S (ZEAL) and Bausch Health Companies (BHC).
When did Sienna Biopharmaceuticals IPO?: Sienna Biopharmaceuticals (SNNA) raised $64 million in an initial public offering on Thursday, July 27th 2017. The company issued 4,300,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Cowen and BMO Capital Markets served as the underwriters for the IPO.

This page (NASDAQ:SNNA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Sienna Biopharmaceuticals (SNNA) Stock Price, News & Analysis

About Sienna Biopharmaceuticals Stock (NASDAQ:SNNA)

SNNA Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

SNNA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info